Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer
- 1 January 1997
- journal article
- Published by Springer Nature in Urological Research
- Vol. 25 (1) , 31-34
- https://doi.org/10.1007/bf00941903
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.1996
- Urinary Cytokines During Intravesical Bacillus Calmetteguerin Therapy for Superficial Bladder Cancer: Processing, Stability and Prognostic ValueJournal of Urology, 1996
- The production of cytokines by polymorphonuclear neutrophilsImmunology Today, 1995
- Increased urinary albumin indicating urothelial leakage following intravesical bacillus Calmette-Guérin therapy for superficial bladder cancerUrological Research, 1993
- Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG)Urological Research, 1993
- Interleukin-8 and the neutrophil response to mucosal gram-negative infection.Journal of Clinical Investigation, 1993
- Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancerUrological Research, 1991
- Neutrophil-Activating Peptide-1/Interleukin-8 Detection in Human Urine during Acute Bladder Inflammation Caused by Transurethral Resection of Superficial Cancer and Bacillus Calmette-Guérin AdministrationEuropean Urology, 1991
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.Journal of Clinical Investigation, 1989
- Mechanisms of action of intravesical BCG for bladder cancer.1989